PATENT CLAIM ANALYSIS

Application Number: 16125252
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "313000"]

Abstract:
Analgesic compositions comprise an aminoquinoline together with an opioid, a non-steroidal anti-inflammatory drug (NSAID), a NE/5-HT reuptake inhibitor, or a combination thereof. The aminoquinoline potentiates bioactivity of opioids, NSAIDs and NE/5-HT reuptake inhibitors.

Claim (Index 43):
The method of  claim 35  wherein the aminoquinoline compound is 5,7-dichloro-4-(3,3-dibutylureido) quinolone-2-carboxylic acid (BCUKA).

Metadata:
- Claim Count in Document: 128.0
- Percentile: 97.0
- Lexical Diversity: 1.32258
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15318964', '12083110', '09171697', '13102705', '15279576']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7531961057752595
- 35 USC 102 Novelty (BERT): 0.6028763651958012
- Combined Prediction Score: 0.7381641317173138
- Mean Citation Score: 349.545086
- Max Citation Score: 563.5349
- Similarity Product: 427.6268920007586

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test